Proportional hazards model
-
TMP/SMX use was linked to fewer severe infections in IIM
Trimethoprim-sulfamethoxazole reduces severe infection risk in idiopathic inflammatory myopathy patients receiving immunosuppressive therapy, with significant protection against respiratory tract.

